BORNHOLMS DENTALLABORATORIUM ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  5.2% 6.8% 3.7% 4.1% 3.6%  
Credit score (0-100)  44 35 50 48 51  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  503 414 629 640 681  
EBITDA  -41.5 -148 108 179 166  
EBIT  -120 -177 80.6 151 140  
Pre-tax profit (PTP)  -142.0 -198.1 65.0 125.7 114.4  
Net earnings  -111.0 -155.1 51.1 97.4 89.2  
Pre-tax profit without non-rec. items  -142 -198 65.0 126 114  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  16.6 13.4 10.6 7.9 6.2  
Shareholders equity total  -211 -366 -315 -217 -128  
Interest-bearing liabilities  30.3 96.8 841 783 639  
Balance sheet total (assets)  688 684 656 649 567  

Net Debt  -211 -133 700 544 421  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  503 414 629 640 681  
Gross profit growth  -18.9% -17.6% 51.9% 1.6% 6.5%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  688 684 656 649 567  
Balance sheet change%  -18.5% -0.6% -4.2% -1.0% -12.7%  
Added value  -41.5 -148.4 108.5 178.7 166.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -156 -56 -56 -55 -53  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 1.0 2.0 3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -23.8% -42.6% 12.8% 23.6% 20.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -13.0% -18.1% 8.0% 16.4% 18.0%  
ROI %  -14.3% -20.5% 9.2% 18.6% 19.8%  
ROE %  -14.5% -22.6% 7.6% 14.9% 14.7%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -23.4% -34.8% -32.4% -25.1% -18.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  510.0% 89.6% 645.8% 304.8% 252.7%  
Gearing %  -14.4% -26.5% -267.2% -360.6% -499.6%  
Net interest  0 0 0 0 0  
Financing costs %  73.8% 33.9% 3.3% 3.1% 3.7%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  3.8 1.8 0.5 0.5 0.6  
Current Ratio  3.8 1.8 0.5 0.5 0.6  
Cash and cash equivalent  241.7 229.7 140.2 239.0 218.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  311.7 200.8 -525.1 -400.0 -284.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -41 -148 108 179 166  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -41 -148 108 179 166  
EBIT / employee  -120 -177 81 151 140  
Net earnings / employee  -111 -155 51 97 89